Skip to main content
Back to OrbiMed

OrbiMed's Medical Portfolio

Browse 45 Medical companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Medical Companies
45
Total Funding in Medical
$4.0B

Medical Portfolio Companies (45)

Export
BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$48.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

San Diego, United States
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Watertown, United States
September 2025
$200.0M
Series A

Founder Contacts

19,000+ verified contacts

MedicalTherapeutics

Leal Therapeutics develops novel therapeutics for patients.

Worcester, United States
August 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedical Device

ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.

Dublin, Ireland
August 2025
$80.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Lyon, France
June 2025
$6.9M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Oakdale, United States
May 2025
$52.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalOncology

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Philadelphia, United States
May 2025
$38.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyMedical

RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.

San Diego, United States
April 2025
$110.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

Raleigh, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

San Mateo, United States
January 2025
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

Watertown, United States
October 2024
$115.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.

Chicago, United States
July 2024
$45.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareMedical DeviceTherapeutics

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

San Francisco, United States
January 2024
$40.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

La Jolla, United States
October 2023
$85.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Health CareHome Health CareMachine LearningMedical DevicemHealthSoftwareTelehealth

TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.

New York, United States
August 2023
$49.0M
Series E

Founder Contacts

19,000+ verified contacts

BiotechnologyData Collection and LabelingHealth CareMedical DeviceWearables

Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.

Boca Raton, United States
December 2025
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaMedical

Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.

San Francisco, United States
January 2026
$82.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceuticalTherapeutics

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

San Diego, United States
November 2025
$115.0M
Series C

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical DeviceNeuroscience

Stairway Medical is a developer of implantable brain-computer interface technology.

Pudong, China
March 2026
$72.6M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CareMedical

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Changping, China
March 2026
$72.8M
Series C

Founder Contacts

19,000+ verified contacts

Business IntelligenceHealth CareMedical

Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.

New York, United States
December 2025
$200.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedical

TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.

Shanghai, China
November 2025
$22.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

Saint-herblain, France
October 2025
$215.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

Health CareHealth DiagnosticsMedical DeviceSoftwareTherapeutics

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

New York, United States
September 2025
$17.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyMedical

Congruence Therapeutics operates as a biotechnology company.

Montréal, Canada
September 2025
$32.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Radnor, United States
September 2025
$287.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

Cloud Data ServicesInformation TechnologyMedical

Rimag is a Shenzhen-based medical imaging service provider.

Beijing, China
April 2025
$25.1M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

San Diego, United States
March 2025
$20.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Bothell, United States
March 2025
$110.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical DeviceTherapeutics

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

Mountain View, United States
January 2025
$32.5M
Undisclosed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

London, United Kingdom
January 2025
$411.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

South San Francisco, United States
December 2024
$100.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Lexington, United States
August 2024
$125.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Brenig Therapeutics develops therapies for neurodegenerative disorders.

Dover, United States
July 2024
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Kadima, Israel
July 2024
$105.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical DeviceOncology

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Cambridge, United States
April 2024
$280.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio